Pine Valley Investments Ltd Liability Co Has $2.21 Million Holdings in Danaher Co. (NYSE:DHR)

Pine Valley Investments Ltd Liability Co raised its holdings in Danaher Co. (NYSE:DHR) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,604 shares of the conglomerate’s stock after buying an additional 128 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in Danaher were worth $2,205,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC increased its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Barclays decreased their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Jefferies Financial Group decreased their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Down 0.2 %

DHR stock opened at $210.65 on Wednesday. The stock’s fifty day simple moving average is $225.79 and its two-hundred day simple moving average is $246.04. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The stock has a market cap of $150.56 billion, a P/E ratio of 39.90, a P/E/G ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm posted $2.09 EPS. Analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.